Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular Cancer
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2019
Price : $35 *
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Germ cell and embryonal neoplasms
- Focus Diagnostic use
- Acronyms TESTPET
- 06 Sep 2019 Planned End Date changed from 30 May 2019 to 30 Dec 2019.
- 06 Sep 2019 Planned primary completion date changed from 30 May 2019 to 30 Dec 2019.
- 06 Sep 2019 Status changed from recruiting to active, no longer recruiting.